BillionToOne, Inc. (BLLN) vs Sotera Health Company (SHC)

BillionToOne, Inc. and Sotera Health Company are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $5.9B against $5.3B — 1.1× the size. Sotera Health Company trades at the lower P/E: 32.1× against 119×. Sotera Health Company has the higher net margin (13.4% vs 8.35%) and the lower return on invested capital (9.82% vs 34.1%). Across the 19 metrics below, Sotera Health Company leads on 12 and BillionToOne, Inc. on 7.

Valuation

Metric BLLN SHC Diagnostics & Research median
P/E 119.22 32.14 33.95
P/S 14.37 4.30 4.87
P/B 10.64 7.87 3.12
Price to free cash flow 172.16 46.45 34.02
EV/EBITDA 94.49 13.41 25.20
EV/Sales 13.22 5.85 5.66
Earnings yield 0.84% 3.11% (1.75%)
Free cash flow yield 0.58% 2.15% (0.13%)

Profitability

Metric BLLN SHC Diagnostics & Research median
Gross margin 71.27% 54.97% 50.89%
Operating margin 10.90% 32.82% (8.57%)
Net margin 8.35% 13.44% (6.37%)
Free cash flow margin 8.35% 9.27% 0.00%
Return on equity 23.27% 27.78% (2.92%)
Return on assets 9.09% 5.01% (6.71%)
Return on invested capital 34.10% 9.82% 0.00%

Growth

Metric BLLN SHC Diagnostics & Research median
Revenue growth (TTM) — 8.15% 7.69%
EPS growth (last fiscal year) 103.40% 68.75% —
Revenue growth, 5-year CAGR — 7.30% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BLLN SHC Diagnostics & Research median
Debt to equity 0.17 3.35 0.11
Current ratio 11.69 2.80 2.02
Net debt to EBITDA (15.70) 3.74 0.78

Dividend

Metric BLLN SHC Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric BLLN SHC Diagnostics & Research median
Market cap 5.89b 5.27b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack